Gillian Murray MPharm

Vascular adverse events - Stages of progression

Saturday 19th November, 11:30

Abstract:

It can be difficult to ascertain worsening ischaemia, and whether the use of hyaluronidase has been successful. Applying the concept of ‘stages’ allows the clinician to monitor any further decline in the tissue. Further understanding of the ‘stages’ of ischaemia allows prediction of wound formation, and whether further methods should be deployed to support tissue healing.  It is also useful to understand the time frame and appreciate when necrosis is likely to develop, this can alleviate panic and allow formation of a more ordered management plan. In this session we share our understanding from practice with our conference delegates to allow them to take control of these unfortunate events.


Hyaluronidase : an overview (risks, dose and dilution)

Saturday 19th November, 16:00

Abstract:

‘The devil you know, or the devil you don’t know’

Hyaluronidase use has exploded in aesthetic medicines, but its use remains unlicensed. How much do we really know about this enzyme? This session introduces some of the things we know, and don’t know. We will discuss allergy testing, swelling reactions, and apply some evidence to the dogma that surrounds this drug.


Antibiotics or steroids in the management of soft tissue filler infection

Sunday 20th November 16:00

Abstract:

‘A tale of two houses’

‘Antibiotics and steroids’, the cure for all. Both classes of medicines are both useful and powerful agents in modern medicine, but how should we deploy them in aesthetics? And what are the considerations prior to use? The choice of antibiotics to treat delayed onset issues of infective sequalae is the subject of much debate, but how do we logically decide what one is needed and when? Why do some infections become chronic and problematic? What are we doing wrong? This session compliments Dr Vaghela’s in aiming to add some clarity to our drug choices.


Gillian Murray MPharm PG Dip Clin Pharm PG Dip Minor Illness INP, CMAC Board member

Gillian Murray is a clinical prescribing pharmacist specialising in aesthetics medicine and holds a clinical academic position at Kings College London (KCL) University. At the university she is working towards her PhD in hyaluronidase.

Pharmacists in the UK can undertake clinical training to work autonomously as prescribing clinicians.

She is a senior lecturer in advanced clinical practice, rheology and pharmacokinetics, and has published several papers supporting the management of complications in aesthetic practice and dermal filler rheology.

Gillian has 18 years’ experience of working in acute trusts within the NHS predominately in her area of speciality - Surgery. She has held the positions of directorate pharmacist to many surgical disciplines including plastics, burns, ICU, vascular and to medical disciplines such as acute medicine, infection, dermatology and rheumatology. 

Passionate about using medicines safely and understanding co morbidities to inform treatment decisions, she set up the group ‘medicine in aesthetics’ which supports aesthetic practitioners. She has worked extensively to support complications and is a founding board member of the Complications in Medical Aesthetic Collaborative (CMAC UK)

Further to her PhD research she has an interest hypersensitivity reactions in aesthetics, HA gel chemistry, rheology and behaviours.